Ladenburg Thalmann Financial Services’s Kura Oncology KURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
$2K Buy
142
+101
+246% +$1.5K ﹤0.01% 5073
2019
Q3
$1K Hold
41
﹤0.01% 5120
2019
Q2
$1K Hold
41
﹤0.01% 5113
2019
Q1
$1K Sell
41
-1
-2% -$15 ﹤0.01% 5078
2018
Q4
$1K Hold
42
﹤0.01% 5052
2018
Q3
$1K Buy
+42
New +$805 ﹤0.01% 4998

Other funds holding KURA

Ladenburg Thalmann Financial Services's KURA Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services increased its Kura Oncology (KURA) stake by 246% in Q4 2019, buying an estimated $1.5K and bringing the position to 142 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #5073.

Ladenburg Thalmann Financial Services first reported a position in KURA in Q3 2018 and has held it in 6 quarters since. 127 funds tracked by Wall St. Rank hold KURA as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 142 shares of Kura Oncology worth $2K as of Q4 2019.
  • Ladenburg Thalmann Financial Services bought 101 Kura Oncology shares in Q4 2019, an estimated $1.5K.
  • Kura Oncology made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #5073 holding.
  • Ladenburg Thalmann Financial Services first reported a position in Kura Oncology in Q3 2018 and has held it in 6 quarters since.
  • 127 funds tracked by Wall St. Rank held Kura Oncology as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.